These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 9789907)

  • 21. Prolactin, subjective well-being and sexual dysfunction: an open label observational study comparing quetiapine with risperidone.
    Westheide J; Cvetanovska G; Albrecht C; Bliesener N; Cooper-Mahkorn D; Creutz C; Hornung WP; Klingmüller D; Lemke MR; Maier W; Schubert M; Sträter B; Kühn KU
    J Sex Med; 2008 Dec; 5(12):2816-26. PubMed ID: 18466271
    [TBL] [Abstract][Full Text] [Related]  

  • 22. ICI 204,636: a new atypical antipsychotic drug.
    Hirsch SR; Link CG; Goldstein JM; Arvanitis LA
    Br J Psychiatry Suppl; 1996 May; (29):45-56. PubMed ID: 8733823
    [No Abstract]   [Full Text] [Related]  

  • 23. Maintenance of long-term efficacy and safety of quetiapine in the open-label treatment of schizophrenia.
    Kasper S; Brecher M; Fitton L; Jones AM
    Int Clin Psychopharmacol; 2004 Sep; 19(5):281-9. PubMed ID: 15289701
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Quetiapine: a well-tolerated and effective atypical antipsychotic.
    Hellewell JS
    Hosp Med; 2002 Oct; 63(10):600-3. PubMed ID: 12422494
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Discriminant cognitive factors in responder and non-responder patients with schizophrenia.
    Stip E; Lussier I; Ngan E; Mendrek A; Liddle P
    Eur Psychiatry; 1999 Dec; 14(8):442-50. PubMed ID: 10683630
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effectiveness of quetiapine versus conventional antipsychotics in improving cognitive and functional outcomes in standard treatment settings.
    Velligan DI; Prihoda TJ; Sui D; Ritch JL; Maples N; Miller AL
    J Clin Psychiatry; 2003 May; 64(5):524-31. PubMed ID: 12755654
    [TBL] [Abstract][Full Text] [Related]  

  • 27. How effective is it to sequentially switch among Olanzapine, Quetiapine and Risperidone?--A randomized, open-label study of algorithm-based antipsychotic treatment to patients with symptomatic schizophrenia in the real-world clinical setting.
    Suzuki T; Uchida H; Watanabe K; Nomura K; Takeuchi H; Tomita M; Tsunoda K; Nio S; Den R; Manki H; Tanabe A; Yagi G; Kashima H
    Psychopharmacology (Berl); 2007 Dec; 195(2):285-95. PubMed ID: 17701027
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Quetiapine fumarate for schizophrenia and bipolar disorder in young patients.
    Ribolsi M; Magni V; Rubino IA
    Drugs Today (Barc); 2010 Aug; 46(8):581-7. PubMed ID: 20830318
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy, safety, and tolerability of quetiapine in patients with schizophrenia.
    Nasrallah HA; Tandon R
    J Clin Psychiatry; 2002; 63 Suppl 13():12-20. PubMed ID: 12562142
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-term maintenance therapy with quetiapine versus haloperidol decanoate in patients with schizophrenia or schizoaffective disorder.
    Glick ID; Marder SR
    J Clin Psychiatry; 2005 May; 66(5):638-41. PubMed ID: 15889952
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Successful outcome using quetiapine in a case of treatment-resistant schizophrenia with assaultive behavior.
    Brooks JO
    Schizophr Res; 2001 May; 50(1-2):133-4. PubMed ID: 11378322
    [No Abstract]   [Full Text] [Related]  

  • 32. Sexual functioning associated with quetiapine switch vs. risperidone continuation in outpatients with schizophrenia or schizoaffective disorder: a randomized double-blind pilot trial.
    Byerly MJ; Nakonezny PA; Rush AJ
    Psychiatry Res; 2008 May; 159(1-2):115-20. PubMed ID: 18295343
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Progressive striatal and hippocampal volume loss in initially antipsychotic-naive, first-episode schizophrenia patients treated with quetiapine: relationship to dose and symptoms.
    Ebdrup BH; Skimminge A; Rasmussen H; Aggernaes B; Oranje B; Lublin H; Baaré W; Glenthøj B
    Int J Neuropsychopharmacol; 2011 Feb; 14(1):69-82. PubMed ID: 20701823
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of olanzapine, quetiapine, and risperidone on neurocognitive function in early psychosis: a randomized, double-blind 52-week comparison.
    Keefe RS; Sweeney JA; Gu H; Hamer RM; Perkins DO; McEvoy JP; Lieberman JA
    Am J Psychiatry; 2007 Jul; 164(7):1061-71. PubMed ID: 17606658
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Quetiapine--efficacy in different domains.
    Sharma T
    Eur Neuropsychopharmacol; 2001 Oct; 11 Suppl 4():S385-90. PubMed ID: 11587885
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cataracts and quetiapine.
    Valibhai F; Phan NB; Still DJ; True J
    Am J Psychiatry; 2001 Jun; 158(6):966. PubMed ID: 11384916
    [No Abstract]   [Full Text] [Related]  

  • 37. Reduction in psychotic symptoms as a predictor of patient satisfaction with antipsychotic medication in schizophrenia: data from a randomized double-blind trial.
    Gharabawi GM; Greenspan A; Rupnow MF; Kosik-Gonzalez C; Bossie CA; Zhu Y; Kalali AH; Awad AG
    BMC Psychiatry; 2006 Oct; 6():45. PubMed ID: 17054789
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Early phase II study of quetiapine fumarate on schizophrenia].
    Murasaki M; Yamauchi T; Yagi G; Nakajima T; Nakane Y; Kudo Y
    Nihon Shinkei Seishin Yakurigaku Zasshi; 1999 Apr; 19(2):53-66. PubMed ID: 10464776
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Improvement in social competence with short-term atypical antipsychotic treatment: a randomized, double-blind comparison of quetiapine versus risperidone for social competence, social cognition, and neuropsychological functioning.
    Harvey PD; Patterson TL; Potter LS; Zhong K; Brecher M
    Am J Psychiatry; 2006 Nov; 163(11):1918-25. PubMed ID: 17074943
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neurocognitive effects of antipsychotic medications in patients with chronic schizophrenia in the CATIE Trial.
    Keefe RS; Bilder RM; Davis SM; Harvey PD; Palmer BW; Gold JM; Meltzer HY; Green MF; Capuano G; Stroup TS; McEvoy JP; Swartz MS; Rosenheck RA; Perkins DO; Davis CE; Hsiao JK; Lieberman JA; ;
    Arch Gen Psychiatry; 2007 Jun; 64(6):633-47. PubMed ID: 17548746
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.